|
UBA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.248100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.378430E-02 |
| Normal-vs-Stage2 |
6.92430000004407E-07 |
| Normal-vs-Stage3 |
2.617200E-03 |
| Normal-vs-Stage4 |
4.45100000000531E-05 |
| Stage1-vs-Stage2 |
2.576300E-04 |
| Stage1-vs-Stage3 |
1.873800E-01 |
| Stage1-vs-Stage4 |
1.391780E-02 |
| Stage2-vs-Stage3 |
2.604400E-02 |
| Stage2-vs-Stage4 |
2.655000E-01 |
| Stage3-vs-Stage4 |
1.943950E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.194000E-04 |
| Normal-vs-AfricanAmerican |
6.277600E-01 |
| Normal-vs-Asian |
1.711400E-01 |
| Caucasian-vs-AfricanAmerican |
1.149990E-01 |
| Caucasian-vs-Asian |
2.127200E-01 |
| AfricanAmerican-vs-Asian |
5.620000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.249500E-04 |
| Normal-vs-Female |
1.644280E-03 |
| Male-vs-Female |
1.066590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.064300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.12719999999456E-05 |
| Normal-vs-Age(61-80Yrs) |
4.32570000000743E-05 |
| Normal-vs-Age(81-100Yrs) |
2.848600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.277400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.195400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.458200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.731200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.764800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.473200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.218400E-01 |
| Classical-VS-Follicular |
1.66029999748574E-08 |
| Classical-VS-Other |
4.032000E-01 |
| Classical-VS-Normal |
6.493700E-02 |
| Tall-VS-Follicular |
1.015300E-03 |
| Tall-VS-Other |
3.944600E-01 |
| Tall-VS-Normal |
3.409400E-01 |
| Follicular-VS-Other |
3.429800E-01 |
| Follicular-VS-Normal |
1.07430000007014E-07 |
| Other-VS-Normal |
9.965900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.05720000004506E-06 |
| Normal-vs-N1 |
1.740260E-02 |
| N0-vs-N1 |
2.354800E-01 |
|
|
